NFKB1 and type 1 diabetes mellitus: Additionally, LNT induces Treg cell proliferation, inhibits the Th1-type immune response, blocks the PI3K/AKT/NF-κB pathway, and demonstrates therapeutic potential for type 1 diabetes mellitus (T1DM) through immunomodulation.